Michael Fehlings

3.7k citations
31 papers · 2.9k · 1 hit paper · h-index 17

Impact in

  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
  • Immunology top 2%
    • T-cell and B-cell Immunology
    • Immunotherapy and Immune Responses
    • IL-33, ST2, and ILC Pathways
    • Immune cells in cancer

Papers in

    • T-cell and B-cell Immunology 6
    • IL-33, ST2, and ILC Pathways 3
    • Immunotherapy and Immune Responses 3
    • Immune cells in cancer 2
    • Cancer Immunotherapy and Biomarkers 12

Michael Fehlings

29 papers receiving 2.9k citations

Michael Fehlings's Hit Papers

Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates 2018 · 1.1k citations
1.1k0+2+5Years since publication2505007501k

Peers

Michael Fehlings
Comparison fields: 5 of 78
  • Oncology 1.3k
  • Immunology 1.1k
  • Infectious Diseases 383
  • Physiology 53
  • Hepatology 74
Replace Chiew Yee Loh with:
Chiew Yee Loh Singapore
Kristin G. Anderson United States
Rony Dahan Israel
Ariane Morel France
Alfonso R. Sánchez-Paulete Spain
Robbert van der Voort Netherlands
Mohamed S. Abdel-Hakeem United States
Michael M. Quigley United States
Junghwa Lee South Korea
Alessandra Nardin United States
Michael Fehlings relative to Chiew Yee Loh Singapore Chiew Yee Loh's profile →
Citations per field
00.5×1.5×2×2.3×
Chiew Yee Loh · 1×
Citations per year

Countries citing papers authored by Michael Fehlings

Since Specialization
Citations

This map shows the geographic impact of Michael Fehlings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Fehlings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Fehlings more than expected).

Fields of papers citing papers by Michael Fehlings

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Fehlings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Fehlings. The network helps show where Michael Fehlings may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Fehlings, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Fehlings Line = papers co-authored together Michael Fehlings links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
Hit paper breakdown →
20181091
2 2016380
3 2018354
4 2021195
5 2020150
6 202182
7 202177
8 201876
9 201876
10 201975
11 202275
12 201958
13 202256
14 202239
15 201828
16 202323
17 202319
18 201711
19 202411
20 202010

About Michael Fehlings

Michael Fehlings is a scholar working on Immunology, Oncology, Infectious Diseases, Molecular Biology and Virology, having authored 31 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), T-cell and B-cell Immunology (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), vaccines and immunoinformatics approaches (3 papers), IL-33, ST2, and ILC Pathways (3 papers), Immunotherapy and Immune Responses (3 papers), Immune cells in cancer (2 papers) and HIV Research and Treatment (1 paper). The work is most often cited by research in Oncology (1.3k citations), Immunology (1.1k citations), Infectious Diseases (383 citations), Physiology (53 citations) and Hepatology (74 citations). Michael Fehlings has collaborated with scholars based in United States, Singapore and United Kingdom. Frequent co-authors include Evan William Newell, Alessandra Nardin, Takuro Noguchi, Ekaterina Esaulova, Stephen T. Oh, Cora D. Arthur, Catrina C. Fronick, Jeffrey P. Ward, Daniele Runci and Matthew M. Gubin. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Immunity, Journal of Clinical Investigation, Cell and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact